pioglitazone has been researched along with anandamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouaboula, M; Casellas, P; Fajas, L; Hilairet, S; Le Fur, G; Marchand, J | 1 |
1 other study(ies) available for pioglitazone and anandamide
| Article | Year |
|---|---|
Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Anilides; Animals; Arachidonic Acids; Binding Sites; Binding, Competitive; Blotting, Western; Cannabinoid Receptor Modulators; Carrier Proteins; CCAAT-Enhancer-Binding Protein-alpha; Cell Differentiation; Cell Line; Chlorocebus aethiops; Chromans; COS Cells; Dose-Response Relationship, Drug; Endocannabinoids; Fibroblasts; Gene Expression; HeLa Cells; Humans; Intercellular Signaling Peptides and Proteins; Luciferases; Mice; Perilipin-1; Phosphoproteins; Pioglitazone; Plasmids; Polyunsaturated Alkamides; PPAR gamma; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; Thiazolidinediones; Transcriptional Activation; Transfection; Troglitazone | 2005 |